President Trump has mentioned imposing tariffs on imported pharmaceuticals, possibly hitting rates as high as 200%. However, he indicated that any actual taxation might not take effect for over a year.
“They’ll get a very high rate of tariffs, like 200%,” Trump stated during a cabinet meeting on Tuesday, yet he acknowledged a delay before these tariffs would be imposed.
“We give them a certain period of time to put together their actions,” he explained, suggesting a timeline of “about a year, year and a half.”
Commerce Secretary Howard Lutnick mentioned to CNBC that more details will be revealed at the end of the month.
“With drugs and semiconductors, these studies were completed at the end of the month, so the president will then set a policy,” he noted.
This proposed tariff is Trump’s most pointed remark regarding drug imports since April when his administration initiated an investigation under Section 232 regarding the national security implications of drug imports.
This legal framework permits the Department of Commerce to recommend trade actions based on security concerns related to imports.
Although Trump has issued threats of high tariffs in the past only to reverse those decisions, it remains uncertain whether the projected 200% rate will actually be enacted.
As of now, pharmaceutical inventory levels have not significantly changed since this announcement.
In a memo released Tuesday, analyst David Risinger from Leerink Partners described the announcement as “positive for the industry” because of the delays in implementation and uncertainties surrounding actual follow-through.
The pharmaceutical sector has raised alarms that such tariffs could boost drug prices, hinder investments, and disrupt supply chains.
“Every dollar spent on tariffs is a dollar that cannot be invested in American manufacturing or in developing future treatments,” Alex Schliver, a senior vice president at PHRMA, stated, emphasizing concerns shared by many in the industry.
Trump’s administration is poised to implement what could be some of the highest tariffs seen in modern trading relationships starting August 1st, unless new trade agreements are negotiated. Previous measures have already stirred worries regarding consumer prices and the stability of the global economy.
Trump disclosed that at least seven countries would soon receive notices concerning new tariffs, with more notices expected shortly.
If 14 nations, including Japan, South Korea, and Malaysia, do not reach trade agreements, they could face these new tariffs by the impending August 1 deadline. Trump affirmed that no extensions would be allowed beyond that date.
